Why Nuclear Investors Should Back Steel, Not Reactor Designs

When investors look at the nuclear revival unfolding across the United States and its allies, the instinct is to pick a reactor. Which design wins? Whose small modular unit gets built first? That instinct points at the wrong target.

The harder constraint sits upstream, in the heavy manufacturing plants that forge the steel every reactor needs regardless of design. As of September 2026, Western permitting reform is moving fast, but the physical procurement reality has barely budged. You can approve a plant in months. You cannot forge a reactor pressure vessel in less than three years.

That gap between paper progress and steel reality is where the money actually concentrates. What follows here separates the reactor logos from the equipment providers, and shows you where capital gets captured in the construction cycle rather than where the headlines land.

Eliminating binary technology risk through the upstream supply chain

The framework worth adopting comes from a research piece by Ocean Wall titled From Blueprint to Fleet: Mapping the Nuclear Trade. Its central idea is deceptively simple: you do not need to know which reactor wins to profit from the build-out. You just need to own the equipment every reactor requires.

Ocean Wall calls the thing you want to avoid “binary technology risk.”

The nuclear investment framework that Ocean Wall applies here represents a broader shift in how institutional capital approaches the sector: away from technology bets and toward structural exposure to the inputs every design must purchase.

Binary technology risk This is the danger of betting your capital on a single reactor design. If that design fails to win contracts, your position can go to zero. Backing the equipment providers instead means you get paid no matter whose logo ends up on the cooling tower.

The economics explain why this works. Capital goods companies, the firms that build the vessels, turbines, and heavy components, capture roughly 50% of a nuclear plant’s total capital expenditure. Capex itself accounts for 70-80% of a project’s total lifetime cost. So a single category of supplier sits astride the largest slice of the largest cost bucket in the entire industry.

That is where the leverage lives, and it is structural rather than speculative.

Ocean Wall built its thesis by mapping the full Westinghouse AP1000 supply chain, then screening 144 companies against a projected 5-year Final Investment Decision (FID) horizon. A Final Investment Decision is the point at which a project’s backers formally commit the capital to build. By scoring companies on deliverability, whether they can actually produce components on time, the firm isolated the suppliers that matter from the ones that merely appear on a list.

This is not theoretical. The screen is live inside the 5T Nuclear Fund, a dedicated vehicle Ocean Wall runs with Zurich-based partner 5T.

The read you should take from this is direct. Backing a reactor designer exposes you to a total loss if the market goes elsewhere. Owning the unavoidable equipment secures your capital across the whole fleet. The rest of the analysis follows that logic to the specific companies bending the steel.

The AP1000 pipeline and the 600-ton forging constraint

The demand side of this trade is staggering. During Q2 2026 disclosures, Cameco marketing materials identified a global development pipeline of up to 91 potential AP1000 reactors, representing roughly 105 GWe of capacity. In the near term, up to 10 U.S. units are supported by Department of Energy (DOE) loans, with up to 10 more flowing from a 2025 Cameco, Brookfield and Department of Commerce partnership targeting commercial operation in the mid-to-late 2030s.

DOE supply chain loans, which include the $17.5 billion facility specifically structured around AP1000 components, are the mechanism that converts political commitment into funded manufacturing slots, giving preferred suppliers a revenue floor before projects reach FID.

That 91-reactor pipeline only matters to your portfolio once you grasp the supply side. Almost every one of these projects must pass through a manufacturing funnel controlled by just five or six companies worldwide.

Manufacturing chokepoints

The bottleneck is physical, not bureaucratic. Reactor pressure vessels, the steel containers that hold the reactor core, carry lead times of 36 months at best and five-plus years in practice. And forging capacity is astonishingly concentrated. Japan Steel Works (JSW) alone controls approximately 80% of the global market for large nuclear forgings.

Three drivers keep this funnel narrow:

• Concentrated forging capacity: Only a handful of plants can shape the 600-tonne steel ingots that ultra-heavy vessels require.
• Capital-intensive expansion: A press like JSW’s 14,000-tonne hydraulic unit in Muroran costs billions of yen, and erecting plus qualifying a new one can take over a decade.
• Stringent certifications: Nuclear-grade forgings must meet ASME and RCC-M standards, demanding years of specialised metallurgy and testing.

Because presses are booked years ahead, developers must commit to manufacturing slots globally before their projects even reach FID. That inversion, ordering the hardware before financing the plant, hands enormous pricing power and revenue visibility to whoever controls the presses.

Sizing the Westinghouse opportunity before the IPO

The clearest proxy for the whole AP1000 pipeline is Westinghouse itself. On 31 July 2026, the company confidentially filed a draft registration statement (Form S-1) with the SEC for a proposed initial public offering. As of mid-September 2026, no public S-1 has been issued.

Ownership currently splits 49% to Cameco and 51% to Brookfield Asset Management and its renewable arm. Industry tracking suggests a target valuation of at least $30 billion, with terms that reportedly let the U.S. government take an 8% stake if that threshold is met. For investors, Cameco remains the only listed route to Westinghouse exposure until the offering prices.

For investors wanting to understand the ownership structure, valuation mechanics, and Cameco exposure in depth, our dedicated guide to the Westinghouse IPO walks through the S-1 filing timeline and what the listing means for existing shareholders.

Doosan and BWXT share the North American capacity advantage

If forging capacity is the chokepoint, two companies show you exactly where allied-nation capital must flow. Doosan Enerbility and BWX Technologies (BWXT) occupy the manufacturing positions that the entire Western pipeline depends on.

Doosan holds a near-monopoly among Western-allied nations for ultra-heavy vessel forgings. It is one of only five or six manufacturers globally capable of handling 600-tonne steel ingots, operating 13,000-tonne and 17,000-tonne forging presses. Its consolidated backlog reached ₩26.3509 trillion in H1 2026, a surge of over ₩10 trillion from the ₩16.2005 trillion recorded in 2024.

BWXT dominates large-scale nuclear manufacturing in North America. Its revenue is unusually stable, with 2025 full-year figures showing Government Operations at roughly $2,350.1 million (about 73%) and Commercial Operations at $853.1 million (about 27%) of $3,198.4 million total revenue. That military-anchored base cushions it against any single reactor programme stalling.

The physical expansion is happening now. BWXT’s Precision Components Group acquisition, closed 6 July 2026, added over 500,000 square feet of U.S. capacity and more than 450 skilled employees, while its Cambridge, Ontario plant expanded by 25%.

When you weigh Doosan’s ₩26 trillion backlog against BWXT’s half-million square feet of new floor space, you are watching nuclear capital deploy in real time, years before any of these plants feed the grid.

Tracking the forward order books

Doosan’s own projection sharpens the picture. The company expects its nuclear-specific order backlog to climb from ₩13.7 trillion in 2026 to ₩27.2 trillion by 2030. For 2026 alone, it targets ₩3.5 trillion from large-scale nuclear projects, ₩1.1 trillion from SMRs, and ₩0.3 trillion from maintenance and services.

That backlog trajectory is the metric that tells you whether the pipeline is converting into real orders or stalling on paper.

Valuation premiums and the ghost of Vogtle

None of this comes cheap, and the optimism has a shadow. Major industrial suppliers now carry rich multiples on the strength of their order books. Siemens Energy trades at roughly 61.6x price-to-earnings against a backlog reported near €146-162 billion, and GE Vernova sits at approximately 60x targeted 2026 earnings. Analysts remain divided on whether five-year order visibility justifies those premiums.

The deeper risk is that downstream failure flows back upstream. Nuclear construction has a history of chronic delay and cost inflation, and equipment suppliers are directly exposed when projects unravel.

The Vogtle project in Georgia is the cautionary tale. Units 3 and 4 finished roughly seven years late at a cost of about $35 billion, nearly double the original budget, with supply chain issues alone adding an estimated $2,000/kW. At the related V.C. Summer project, only 100 of 146 modules arrived on time, the remaining 46 delayed by 6-18 months.

Contrast that with China’s follow-on builds. Sanmen 1 reached commercial operation just 158 days after fuel load began on 25 April 2018, as a maturing local manufacturing base slashed lead times for the heaviest components.

China’s fleet-based construction model, which treats each successive reactor as a manufacturing iteration rather than a bespoke project, is precisely why Sanmen 1 reached commercial operation 158 days after fuel load while Western builds absorb years of rework and cost escalation.

You have to balance the equipment thesis against that history. If Western projects hit Vogtle-scale delays, the cost pressure will squeeze supplier margins through renegotiations and cancellations. The other external threats are worth watching too:

• Political phase-outs: Policy reversals, as seen historically in Germany, can erase equipment demand outright.
• Chinese state-backed competition: State-owned OEMs leverage domestic financing to undercut global pricing in Asia, Africa and Latin America.
• Single-facility disruption: A disaster at one critical plant such as JSW could paralyse global deployment schedules at once.

Positioning capital ahead of the 2030 capacity crunch

The core argument holds. The most defensible nuclear investment sits with the companies bending the steel, not the ones mining uranium or designing reactors. Owning the forging chokepoint captures roughly half of every plant’s capex while sidestepping the binary risk of any single design.

The Westinghouse IPO, once it prices, will act as a bellwether for how public markets value Western nuclear as a whole. Watch it closely; it will reset the reference point for the entire sector.

For the next 12-24 months, the metric that matters most is backlog conversion. Track whether Doosan’s ₩26 trillion order book and BWXT’s expanded capacity actually translate into delivered components rather than deferred commitments. That conversion rate is the truest signal of supply chain health.

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions. Past performance does not guarantee future results, and financial projections are subject to market conditions and various risk factors.